Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 125 citing articles:

Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer
Remya Raja, Kiran K. Mangalaparthi, Anil K. Madugundu, et al.
Science Advances (2025) Vol. 11, Iss. 8
Closed Access
The Origin and Immune Recognition of Tumor-Specific Antigens
Anca Apavaloaei, Marie‐Pierre Hardy, Pierre Thibault, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2607-2607
Open Access | Times Cited: 48
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Mass Spectrometry-Based Identification of MHC-Associated Peptides
Sachin Kote, Artur Piróg, Georges Bedran, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 535-535
Open Access | Times Cited: 41
Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?
Ligong Lu, Jun Jiang, Meixiao Zhan, et al.
Hepatology (2020) Vol. 73, Iss. 1, pp. 414-421
Closed Access | Times Cited: 39
Immunopeptidomic Analyses of Colorectal Cancers With and Without Microsatellite Instability
Jenna Cleyle, Marie‐Pierre Hardy, Robin Minati, et al.
Molecular & Cellular Proteomics (2022) Vol. 21, Iss. 5, pp. 100228-100228
Open Access | Times Cited: 27
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
Zaoqu Liu, Jinxiang Lv, Qin Dang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5607-5623
Open Access | Times Cited: 27
Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
Masahiro Okada, Kanako Shimizu, Shin‐ichiro Fujii
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2594-2594
Open Access | Times Cited: 23
The biogenesis of the immunopeptidome
Arie Admon
Seminars in Immunology (2023) Vol. 67, pp. 101766-101766
Open Access | Times Cited: 15
Antigen discovery for the development of cancer immunotherapy
Ryuhjin Ahn, Yufei Cui, Forest M. White
Seminars in Immunology (2023) Vol. 66, pp. 101733-101733
Open Access | Times Cited: 12
Emerging Methods and Techniques for Cancer Biomarker Discovery
Tikam Chand Dakal, Ramgopal Dhakar, Abhijit Beura, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155567-155567
Closed Access | Times Cited: 4
SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells
Melissa Bernhardt, Anne Rech, Marion Berthold, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy
Xiaomeng Guo, Junqiang Bai, Xinmiao Wang, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114576-114576
Closed Access
Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies
Ligong Lu, Jun Jiang, Meixiao Zhan, et al.
Hepatology (2020) Vol. 73, Iss. 2, pp. 821-832
Closed Access | Times Cited: 35
IFNγ Modulates the Immunopeptidome of Triple Negative Breast Cancer Cells by Enhancing and Diversifying Antigen Processing and Presentation
Gabriel Gonçalves, Kerry A. Mullan, Divya Duscharla, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
Advances in immunotherapy for MMR proficient colorectal cancer
Hazel Lote, Naureen Starling, Rille Pihlak, et al.
Cancer Treatment Reviews (2022) Vol. 111, pp. 102480-102480
Open Access | Times Cited: 21
The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Georges Bedran, Hans-Christof Gasser, Kenneth Weke, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 6, pp. 747-762
Open Access | Times Cited: 10
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 3
Empirical and Rational Design of T Cell Receptor-Based Immunotherapies
Heather F. Jones, Zaki Molvi, Martin G. Klatt, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 26
An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens
Niclas Olsson, Marlene L. Heberling, Lichao Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue
Tomomi Hirama, Serina Tokita, Munehide Nakatsugawa, et al.
JCI Insight (2021) Vol. 6, Iss. 14
Open Access | Times Cited: 24
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification
Sara Feola, Markus Haapala, Karita Peltonen, et al.
ACS Nano (2021) Vol. 15, Iss. 10, pp. 15992-16010
Open Access | Times Cited: 23
Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations
Yuriko Minegishi, Kazuma Kiyotani, Kensaku Nemoto, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 16
The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
Yaya Yu, Yan-juan Zhu, Zhenzhen Xiao, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 16
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
María San Román, Javier Torres-Jiménez, Javier Pozas, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 863-863
Open Access | Times Cited: 10

Scroll to top